SCHEMBL1878775

SCHEMBL1878775

Fc1cc2c(Cl)ccnc2c(F)c1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 4/20 0.37
HSP90AA1 P07900 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
TDP1 Q9NUW8 3/20 0.37
LMNA P02545 3/20 0.37
MAPT P10636 3/20 0.37
MMP14 P50281 3/20 0.37
TP53 P04637 2/20 0.37
CYP3A4 P08684 2/20 0.37
ALOX15 P16050 2/20 0.37
ALOX12 P18054 2/20 0.37
SLC6A2 P23975 2/20 0.37
OPRK1 P41145 2/20 0.37
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALOX15B O15296 1/20 0.37
NR1I2 O75469 1/20 0.37
HTR1A P08908 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27163581 0.78 KDM4E (0.35) KDM4EALDH1A1HSP90AA1MEN1KMT2A
4-Chloro-6,8-Difluoroquinoline SCHEMBL264453 0.77 CDK8 (0.43) KDM4EALDH1A1HSP90AA1MEN1KMT2A
4-Chloro-6,8-Difluoroquinoline SCHEMBL30225421 0.77 CDK8 (0.43) KDM4EALDH1A1HSP90AA1MEN1KMT2A
SCHEMBL20293018 0.74 KDM4E (0.35) KDM4EALDH1A1HSP90AA1MEN1KMT2A
SCHEMBL4655567 0.72 AXL (0.42) MEN1KMT2ATDP1MAPTALOX15
SCHEMBL22233797 0.72 KDM4E (0.39) KDM4EALDH1A1HSP90AA1MEN1KMT2A
SCHEMBL7014902 0.71 NR4A2 (0.48) KDM4EALDH1A1HSP90AA1MEN1KMT2A
SCHEMBL25130366 0.71 ALOX5AP (0.39) KDM4EALDH1A1HSP90AA1MEN1KMT2A
SCHEMBL5639499 0.71 MAPT (0.43) MEN1KMT2ATDP1MAPTALOX15
SCHEMBL30543147 0.71 KDM4E (0.53) KDM4EALDH1A1HSP90AA1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110256092-A1 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION SUPERGEN, INC. (US) 2011-10-20 US disclosed
US-7939546-B2 Quinoline derivatives for modulating DNA methylation SUPERGEN, INC. (US) 2011-05-10 US disclosed
US-7790746-B2 Quinoline derivatives for modulating DNA methylation SUPERGEN, INC. (US) 2010-09-07 US disclosed
EP-2205586-A1 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION SuperGen, Inc. (US) 2010-07-14 EP disclosed
US-20100129320-A1 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION SUPERGEN, INC. (US) 2010-05-27 US disclosed
EP-2174938-A1 Quinoline derivatives for modulating DNA methylation SuperGen, Inc. (US) 2010-04-14 EP disclosed
US-20090285772-A1 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION SUPERGEN, INC. (US) 2009-11-19 US disclosed
EP-2078008-A2 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION SuperGen, Inc. (US) 2009-07-15 EP disclosed
US-20090099106-A1 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION SUPERGEN, INC. (US) 2009-04-16 US disclosed
WO-2009049132-A1 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION SUPERGEN, INC. (US) 2009-04-16 WO disclosed
US-20080175814-A1 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION SUPERGEN, INC. (US) 2008-07-24 US disclosed
WO-2008046085-A2 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION SUPERGEN, INC. (US) 2008-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080175814-A1 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION DNMT1, DNMT3A, DNMT3L KDM4E 65/4885ALDH1A1 1297/4885HSP90AA1 3616/4885
US-20110256092-A1 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION DNMT1, DNMT3A, DNMT3L KDM4E 65/4885ALDH1A1 1297/4885HSP90AA1 3616/4885
US-20090285772-A1 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION DNMT1, DNMT3A, DNMT3L KDM4E 65/4885ALDH1A1 1297/4885HSP90AA1 3616/4885
US-20090099106-A1 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION DNMT1, DNMT3A, DNMT3L KDM4E 65/4885ALDH1A1 1297/4885HSP90AA1 3616/4885
US-20100129320-A1 QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION DNMT1, DNMT3A, DNMT3L KDM4E 65/4885ALDH1A1 1297/4885HSP90AA1 3616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.